○Tadashi Nakagawa^1,2, Kohei Mori³, Nodoka Shimogaki³, Naoki Shirota³, Yosuke Yamawaki^3,4, Kyoko Kitagawa⁵, Eiryo Kawakami^6,7, Koichiro Ozawa³, Toru Hosoi^1,3 (1. Fac. Pharm. Sci., Sanyo-Onoda City Univ., 2. Grad. Sch. Med., Tohoku Univ., 3. Fac. Pharm. Sci., Hiroshima Univ., 4. Fac. Pharm. Sci., Daiichi Univ. of Pharm., 5. Fac. Med., Univ. of Miyazaki, 6. Grad. Sch. Med., Chiba Univ., 7. RIKEN Information R&D and Strategy Headquarters)

○Shunsuke Takaoka¹, Yoko Ogino¹, Fumiaki Uchiumi¹ (1. Fac. Pharm. Sci., Tokyo Univ. Sci.)

○Keisuke Noguchi¹, Risa Onizawa¹, Ryota Abe¹, Yoko Ike¹, Toru Sengoku², Kazuhiro Ogata², Yoko Ino³, Yayoi Kimura³, Hidefumi Suzuki¹, Hidehisa Takahashi¹ (1. Dept. of Mol. Biol., Grad. Sch. Med. Sci., Yokohama city Univ., 2. Dept. of Biockem., Grad. Sch. Med. Sci., Yokohama City Univ., 3. Adv. Med. Res. Cent., Yokohama city Univ)

○Ai Sakaguchi¹, Daisuke Aibara¹, Kohei Matsuo¹, Kimihiko Matsusue¹ (1. Faculty of Pharmaceutical Science, Fukuoka University)

○Takanobu Kobayashi¹, Takayuki Ohshima², Aya Yokota-Nakatsuma¹, Yoshiharu Ohoka¹ (1. Kagawa Sch. Pharm. Sci., Tokushima Bunri Univ., 2. Fac. Sci. Eng., Tokushima Bunri Univ.)